Post Concurrent Chemoradiation Therapy: Management of Patients Who Do Not Progress
Рет қаралды 275
Learn from Dr Mark Socinski on potential treatment for eligible patients with
unresectable Stage III non-small cell lung cancer (NSCLC) who have not progressed after concurrent chemoradiation and helping to manage potential adverse events associated with the treatment.
Experts’ Perspectives on Radiation Planning and Advances in Radiation Techniques for Stage III NSCLC
Lung Cancer Connect, sponsored by AZ Oncology
Рет қаралды 880